Topics
Atypical teratoid/rhabdoid tumor | Treatment | Immunotherapy | Viruses
Home > Publications > Topics > Atypical teratoid/rhabdoid tumor > Treatment > Immunotherapy > Viruses
Yu
B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J,
Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S,
Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni
MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS,
Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K,
Kasahara N, Diaz AA, Mueller S.
Measles
oncolytic virus as an immunotherapy for recurrent/refractory
pediatric medulloblastoma and atypical teratoid rhabdoid tumor:
results from PNOC005.
Clin
Cancer Res. 2025 Jun 20. doi:
10.1158/1078-0432.CCR-24-3721. PMID:
40540301. Interventional study˰
ˍ